APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Hyperimmune Globulins

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Hyperimmune Globulins Industry Growth and Trends Forecast to 2032

27 December 2025106 pages

Choose your research edition.

Industry ResearchHuman Hyperimmune Globulins Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Hyperimmune Globulins Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Human Hyperimmune Globulins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Hyperimmune Globulins Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Hyperimmune Globulins Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Hyperimmune Globulins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Hyperimmune Globulins is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Hyperimmune Globulins is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Hyperimmune Globulins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Hyperimmune Globulins include CNBG, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, CBPO, Kedrion, Kamada, Grifols and Emergent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Hyperimmune Globulins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Hyperimmune Globulins market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Hyperimmune Globulins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Hyperimmune Globulins.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Hyperimmune Globulins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Hyperimmune Globulins Market by Company

CNBG

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

CBPO

Kedrion

Kamada

Grifols

Emergent

CSL Behring

Biotest

ADMA Biologics

Human Hyperimmune Globulins Segment by Type

Varicella-Zoster Immune Globulin

Cytomegalovirus Immune Globulin

Rho(D) Immune Globulin

Rabies Immuneglobulins

Tetanus Toxin Immuneglobulins

Hepatitis B Immuneglobulins

Others

Human Hyperimmune Globulins Segment by Application

Government Institutions

Private Sector

Others

Human Hyperimmune Globulins Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Hyperimmune Globulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Hyperimmune Globulins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Hyperimmune Globulins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Hyperimmune Globulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Hyperimmune Globulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Varicella-Zoster Immune Globulin Table 2. Major Company of Cytomegalovirus Immune Globulin Table 3. Major Company of Rho(D) Immune Globulin Table 4. Major Company of Rabies Immuneglobulins Table 5. Major Company of Tetanus Toxin Immuneglobulins Table 6. Major Company of Hepatitis B Immuneglobulins Table 7. Major Company of Others Table 8. Global Human Hyperimmune Globulins Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Human Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 10. Global Human Hyperimmune Globulins Sales Market Share in Volume by Type (2021-2026) Table 11. Global Human Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 12. Global Human Hyperimmune Globulins Sales Market Share in Value by Type (2021-2026) Table 13. Global Human Hyperimmune Globulins Price by Type (2021-2026) & (US$/Unit) Table 14. Global Human Hyperimmune Globulins Sales by Type (2027-2032) & (K Units) Table 15. Global Human Hyperimmune Globulins Sales Market Share in Volume by Type (2027-2032) Table 16. Global Human Hyperimmune Globulins Sales by Type (2027-2032) & (US$ Million) Table 17. Global Human Hyperimmune Globulins Sales Market Share in Value by Type (2027-2032) Table 18. Global Human Hyperimmune Globulins Price by Type (2027-2032) & (US$/Unit) Table 19. North America Human Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 20. North America Human Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Human Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 22. Europe Human Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Human Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Human Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Human Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 26. Latin America Human Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Human Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Human Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 29. Human Hyperimmune Globulins Industry Trends Table 30. Human Hyperimmune Globulins Industry Drivers Table 31. Human Hyperimmune Globulins Industry Opportunities and Challenges Table 32. Human Hyperimmune Globulins Industry Restraints Table 33. Global Human Hyperimmune Globulins Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Human Hyperimmune Globulins Revenue Market Share by Company (2021-2026) Table 35. Global Human Hyperimmune Globulins Sales by Company (2021-2026) & (K Units) Table 36. Global Human Hyperimmune Globulins Sales Share by Company (2021-2026) Table 37. Global Human Hyperimmune Globulins Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Human Hyperimmune Globulins Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Human Hyperimmune Globulins Major Company Production Sites and Headquarters Table 40. Global Human Hyperimmune Globulins Company, Product Type & Application Table 41. Global Human Hyperimmune Globulins Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Human Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Human Hyperimmune Globulins Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Human Hyperimmune Globulins Sales by Region (2021-2026) & (K Units) Table 46. Global Human Hyperimmune Globulins Sales Market Share in Volume by Region (2021-2026) Table 47. Global Human Hyperimmune Globulins Sales by Region (2021-2026) & (US$ Million) Table 48. Global Human Hyperimmune Globulins Sales Market Share in Value by Region (2021-2026) Table 49. Global Human Hyperimmune Globulins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Human Hyperimmune Globulins Sales by Region (2027-2032) & (K Units) Table 51. Global Human Hyperimmune Globulins Sales Market Share in Volume by Region (2027-2032) Table 52. Global Human Hyperimmune Globulins Sales by Region (2027-2032) & (US$ Million) Table 53. Global Human Hyperimmune Globulins Sales Market Share in Value by Region (2027-2032) Table 54. Global Human Hyperimmune Globulins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Human Hyperimmune Globulins Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Human Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 57. Global Human Hyperimmune Globulins Sales Market Share in Volume by Application (2021-2026) Table 58. Global Human Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 59. Global Human Hyperimmune Globulins Sales Market Share in Value by Application (2021-2026) Table 60. Global Human Hyperimmune Globulins Price by Application (2021-2026) & (US$/Unit) Table 61. Global Human Hyperimmune Globulins Sales by Application (2027-2032) & (K Units) Table 62. Global Human Hyperimmune Globulins Sales Market Share in Volume by Application (2027-2032) Table 63. Global Human Hyperimmune Globulins Sales by Application (2027-2032) & (US$ Million) Table 64. Global Human Hyperimmune Globulins Sales Market Share in Value by Application (2027-2032) Table 65. Global Human Hyperimmune Globulins Price by Application (2027-2032) & (US$/Unit) Table 66. North America Human Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 67. North America Human Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Human Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 69. Europe Human Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Human Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Human Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Human Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 73. Latin America Human Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Human Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Human Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 76. CNBG Company Information Table 77. CNBG Business Overview Table 78. CNBG Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CNBG Human Hyperimmune Globulins Product Portfolio Table 80. CNBG Recent Development Table 81. Sichuan Yuanda Shuyang Company Information Table 82. Sichuan Yuanda Shuyang Business Overview Table 83. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product Portfolio Table 85. Sichuan Yuanda Shuyang Recent Development Table 86. Shanghai RAAS Company Information Table 87. Shanghai RAAS Business Overview Table 88. Shanghai RAAS Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanghai RAAS Human Hyperimmune Globulins Product Portfolio Table 90. Shanghai RAAS Recent Development Table 91. Hualan Bio Company Information Table 92. Hualan Bio Business Overview Table 93. Hualan Bio Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hualan Bio Human Hyperimmune Globulins Product Portfolio Table 95. Hualan Bio Recent Development Table 96. CBPO Company Information Table 97. CBPO Business Overview Table 98. CBPO Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. CBPO Human Hyperimmune Globulins Product Portfolio Table 100. CBPO Recent Development Table 101. Kedrion Company Information Table 102. Kedrion Business Overview Table 103. Kedrion Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Kedrion Human Hyperimmune Globulins Product Portfolio Table 105. Kedrion Recent Development Table 106. Kamada Company Information Table 107. Kamada Business Overview Table 108. Kamada Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Kamada Human Hyperimmune Globulins Product Portfolio Table 110. Kamada Recent Development Table 111. Grifols Company Information Table 112. Grifols Business Overview Table 113. Grifols Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Grifols Human Hyperimmune Globulins Product Portfolio Table 115. Grifols Recent Development Table 116. Emergent Company Information Table 117. Emergent Business Overview Table 118. Emergent Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Emergent Human Hyperimmune Globulins Product Portfolio Table 120. Emergent Recent Development Table 121. CSL Behring Company Information Table 122. CSL Behring Business Overview Table 123. CSL Behring Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. CSL Behring Human Hyperimmune Globulins Product Portfolio Table 125. CSL Behring Recent Development Table 126. Biotest Company Information Table 127. Biotest Business Overview Table 128. Biotest Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Biotest Human Hyperimmune Globulins Product Portfolio Table 130. Biotest Recent Development Table 131. ADMA Biologics Company Information Table 132. ADMA Biologics Business Overview Table 133. ADMA Biologics Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. ADMA Biologics Human Hyperimmune Globulins Product Portfolio Table 135. ADMA Biologics Recent Development Table 136. North America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Human Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 138. North America Human Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 139. North America Human Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Human Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 141. North America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Human Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Human Hyperimmune Globulins Market Share by Country (2021-2026) Table 144. North America Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Human Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 146. Europe Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Human Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 148. Europe Human Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 149. Europe Human Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Human Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Human Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Human Hyperimmune Globulins Market Share by Country (2021-2026) Table 154. Europe Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Human Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Human Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Human Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Human Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Human Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Human Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Human Hyperimmune Globulins Market Share by Country (2021-2026) Table 164. Asia-Pacific Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Human Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 166. Latin America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Human Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 168. Latin America Human Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 169. Latin America Human Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Human Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Human Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Human Hyperimmune Globulins Market Share by Country (2021-2026) Table 174. Latin America Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Human Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Human Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Human Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Human Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Human Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Human Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Human Hyperimmune Globulins Market Share by Country (2021-2026) Table 184. Middle East and Africa Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Human Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Human Hyperimmune Globulins Distributors List Table 189. Human Hyperimmune Globulins Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Human Hyperimmune Globulins Image Figure 2. Global Human Hyperimmune Globulins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Hyperimmune Globulins Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Hyperimmune Globulins Sales (2021-2032) & (K Units) Figure 5. Varicella-Zoster Immune Globulin Image Figure 6. Global Varicella-Zoster Immune Globulin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Cytomegalovirus Immune Globulin Image Figure 8. Global Cytomegalovirus Immune Globulin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Rho(D) Immune Globulin Image Figure 10. Global Rho(D) Immune Globulin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Rabies Immuneglobulins Image Figure 12. Global Rabies Immuneglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 13. Tetanus Toxin Immuneglobulins Image Figure 14. Global Tetanus Toxin Immuneglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 15. Hepatitis B Immuneglobulins Image Figure 16. Global Hepatitis B Immuneglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Human Hyperimmune Globulins Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Human Hyperimmune Globulins Market Share by Type 2025 VS 2032 Figure 21. North America Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 22. North America Human Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 23. Europe Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 24. Europe Human Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 27. Latin America Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Human Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Human Hyperimmune Globulins Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Government Institutions Image Figure 34. Global Government Institutions Sales YoY Growth (2021-2032) & (K Units) Figure 35. Private Sector Image Figure 36. Global Private Sector Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Human Hyperimmune Globulins Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Human Hyperimmune Globulins Market Share by Application 2025 VS 2032 Figure 41. North America Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 42. North America Human Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 43. Europe Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 44. Europe Human Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 47. Latin America Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Human Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 51. North America Human Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Human Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Human Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Human Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Human Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Human Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Human Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Human Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Human Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Human Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Human Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Human Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Human Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Human Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Human Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Human Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Human Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Human Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Human Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Human Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Human Hyperimmune Globulins Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Human Hyperimmune Globulins Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Varicella-Zoster Immune Globulin
  • Cytomegalovirus Immune Globulin
  • Rho(D) Immune Globulin
  • Rabies Immuneglobulins
  • Tetanus Toxin Immuneglobulins
  • Hepatitis B Immuneglobulins
  • Others
Applications
  • Government Institutions
  • Private Sector
  • Others
Companies covered
  • CNBG
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • CBPO
  • Kedrion
  • Kamada
  • Grifols
  • Emergent
  • CSL Behring
  • Biotest
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Hyperimmune Globulins Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Hyperimmune Globulins Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Hyperimmune Globulins Market by Type
  6. 1.3.1 Varicella-Zoster Immune Globulin
  7. 1.3.2 Cytomegalovirus Immune Globulin
  8. 1.3.3 Rho(D) Immune Globulin
  9. 1.3.4 Rabies Immuneglobulins
  10. 1.3.5 Tetanus Toxin Immuneglobulins
  11. 1.3.6 Hepatitis B Immuneglobulins
  12. 1.3.7 Others
  13. 1.4 Global Human Hyperimmune Globulins Market Size by Type
  14. 1.4.1 Global Human Hyperimmune Globulins Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Human Hyperimmune Globulins Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Human Hyperimmune Globulins Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Human Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Human Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Human Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Human Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Human Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Hyperimmune Globulins Industry Trends
  2. 2.2 Human Hyperimmune Globulins Industry Drivers
  3. 2.3 Human Hyperimmune Globulins Industry Opportunities and Challenges
  4. 2.4 Human Hyperimmune Globulins Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Hyperimmune Globulins Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Hyperimmune Globulins Sales (2021-2026)
  3. 3.3 Global Top Players by Human Hyperimmune Globulins Price (2021-2026)
  4. 3.4 Global Human Hyperimmune Globulins Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Hyperimmune Globulins Major Company Production Sites & Headquarters
  6. 3.6 Global Human Hyperimmune Globulins Company, Product Type & Application
  7. 3.7 Global Human Hyperimmune Globulins Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Hyperimmune Globulins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Hyperimmune Globulins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Hyperimmune Globulins Tier 1, Tier 2, and Tier 3
4 Human Hyperimmune Globulins Regional Status and Outlook
  1. 4.1 Global Human Hyperimmune Globulins Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Hyperimmune Globulins Historic Market Size by Region
  3. 4.2.1 Global Human Hyperimmune Globulins Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Hyperimmune Globulins Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Hyperimmune Globulins Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Hyperimmune Globulins Forecasted Market Size by Region
  7. 4.3.1 Global Human Hyperimmune Globulins Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Hyperimmune Globulins Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Hyperimmune Globulins Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Hyperimmune Globulins by Application
  1. 5.1 Human Hyperimmune Globulins Market by Application
  2. 5.1.1 Government Institutions
  3. 5.1.2 Private Sector
  4. 5.1.3 Others
  5. 5.2 Global Human Hyperimmune Globulins Market Size by Application
  6. 5.2.1 Global Human Hyperimmune Globulins Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Hyperimmune Globulins Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Hyperimmune Globulins Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CNBG
  2. 6.1.1 CNBG Company Information
  3. 6.1.2 CNBG Business Overview
  4. 6.1.3 CNBG Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CNBG Human Hyperimmune Globulins Product Portfolio
  6. 6.1.5 CNBG Recent Developments
  7. 6.2 Sichuan Yuanda Shuyang
  8. 6.2.1 Sichuan Yuanda Shuyang Company Information
  9. 6.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 6.2.3 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product Portfolio
  12. 6.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 6.3 Shanghai RAAS
  14. 6.3.1 Shanghai RAAS Company Information
  15. 6.3.2 Shanghai RAAS Business Overview
  16. 6.3.3 Shanghai RAAS Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai RAAS Human Hyperimmune Globulins Product Portfolio
  18. 6.3.5 Shanghai RAAS Recent Developments
  19. 6.4 Hualan Bio
  20. 6.4.1 Hualan Bio Company Information
  21. 6.4.2 Hualan Bio Business Overview
  22. 6.4.3 Hualan Bio Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Bio Human Hyperimmune Globulins Product Portfolio
  24. 6.4.5 Hualan Bio Recent Developments
  25. 6.5 CBPO
  26. 6.5.1 CBPO Company Information
  27. 6.5.2 CBPO Business Overview
  28. 6.5.3 CBPO Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CBPO Human Hyperimmune Globulins Product Portfolio
  30. 6.5.5 CBPO Recent Developments
  31. 6.6 Kedrion
  32. 6.6.1 Kedrion Company Information
  33. 6.6.2 Kedrion Business Overview
  34. 6.6.3 Kedrion Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kedrion Human Hyperimmune Globulins Product Portfolio
  36. 6.6.5 Kedrion Recent Developments
  37. 6.7 Kamada
  38. 6.7.1 Kamada Company Information
  39. 6.7.2 Kamada Business Overview
  40. 6.7.3 Kamada Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kamada Human Hyperimmune Globulins Product Portfolio
  42. 6.7.5 Kamada Recent Developments
  43. 6.8 Grifols
  44. 6.8.1 Grifols Company Information
  45. 6.8.2 Grifols Business Overview
  46. 6.8.3 Grifols Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Grifols Human Hyperimmune Globulins Product Portfolio
  48. 6.8.5 Grifols Recent Developments
  49. 6.9 Emergent
  50. 6.9.1 Emergent Company Information
  51. 6.9.2 Emergent Business Overview
  52. 6.9.3 Emergent Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Emergent Human Hyperimmune Globulins Product Portfolio
  54. 6.9.5 Emergent Recent Developments
  55. 6.10 CSL Behring
  56. 6.10.1 CSL Behring Company Information
  57. 6.10.2 CSL Behring Business Overview
  58. 6.10.3 CSL Behring Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CSL Behring Human Hyperimmune Globulins Product Portfolio
  60. 6.10.5 CSL Behring Recent Developments
  61. 6.11 Biotest
  62. 6.11.1 Biotest Company Information
  63. 6.11.2 Biotest Business Overview
  64. 6.11.3 Biotest Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biotest Human Hyperimmune Globulins Product Portfolio
  66. 6.11.5 Biotest Recent Developments
  67. 6.12 ADMA Biologics
  68. 6.12.1 ADMA Biologics Company Information
  69. 6.12.2 ADMA Biologics Business Overview
  70. 6.12.3 ADMA Biologics Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ADMA Biologics Human Hyperimmune Globulins Product Portfolio
  72. 6.12.5 ADMA Biologics Recent Developments
7 North America by Country
  1. 7.1 North America Human Hyperimmune Globulins Sales by Country
  2. 7.1.1 North America Human Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Hyperimmune Globulins Sales by Country (2021-2026)
  4. 7.1.3 North America Human Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Hyperimmune Globulins Market Size by Country
  6. 7.2.1 North America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Hyperimmune Globulins Sales by Country
  2. 8.1.1 Europe Human Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Hyperimmune Globulins Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Hyperimmune Globulins Market Size by Country
  6. 8.2.1 Europe Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Hyperimmune Globulins Sales by Country
  2. 9.1.1 Asia-Pacific Human Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Hyperimmune Globulins Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Hyperimmune Globulins Market Size by Country
  6. 9.2.1 Asia-Pacific Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Hyperimmune Globulins Sales by Country
  2. 10.1.1 South America Human Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Hyperimmune Globulins Sales by Country (2021-2026)
  4. 10.1.3 South America Human Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Hyperimmune Globulins Market Size by Country
  6. 10.2.1 South America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Hyperimmune Globulins Sales by Country
  2. 11.1.1 Middle East and Africa Human Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Hyperimmune Globulins Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Hyperimmune Globulins Market Size by Country
  6. 11.2.1 Middle East and Africa Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Hyperimmune Globulins Value Chain Analysis
  2. 12.1.1 Human Hyperimmune Globulins Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Hyperimmune Globulins Production Mode & Process
  7. 12.2 Human Hyperimmune Globulins Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Hyperimmune Globulins Distributors
  10. 12.2.3 Human Hyperimmune Globulins Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst